All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
CHICAGO — Community gastroenterologists spend about a third of their time doing upper endoscopies on patients with gastric reflux in an effort to identify which of those patients have Barrett's esophagus (BE), a pre-cancerous condition characterized by esophageal goblet cell metaplasia. This is easier said than done, however, because the current gold standard for detecting BE is akin to a guessing game.